Tishman Speyer signs global pharma firm for Paddington scheme
The investor and developer has signed pharmaceutical firm Ipsen Biopharm for 18,000 sq ft.
The investor and developer has signed pharmaceutical firm Ipsen Biopharm for 18,000 sq ft.
